Epidemiologic, clinical and microbiological characteristics of nosocomial urinary infection in the spinal cord lesioned patient;Características epidemiológicas, clínicas y microbiológicas de las infecciones nosocomiales urinarias en las lesiones medulares espinales

Actas Urologicas Espanolas

Volumn 31, Issue 7, 2007, Pages 764-770

  Hernández Gonzĺez, Elizabeth ^a,b   Zamora Perez F ^a   Martinez Arroyo, M ^a   Valdez Fernandez M ^a   Alberti Amador, E ^a  

^a NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

^b NONE   (Cuba)

Author keywords

E. coli; Neurogenic bladder; Spinal cord injures; Urinary tract infections

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CROSS INFECTION; FEMALE; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; SPINAL CORD INJURY; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; CROSS INFECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPINAL CORD INJURIES; URINARY TRACT INFECTIONS;

EID: 38449092767     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0210-4806(07)73719-1     Document Type: Article

References (36)

1. Prevalencia de infecciones nosocomiales en hospitales españoles, Estudio EPINE. [Sitio en Internet] Disponible en: Con acceso el 26 de abril de 2005.
2. Harrop JS, Sharan AD, Przybylski GJ. Epidemiology of Spinal Cord Injury After Acute Odontoid Fractures. Neurosurg Focus 8(6).
3. Nickel JC, Costerton JW, McLean RJ. Bacterial biofilms: influence on the pathogenesis, diagnosis and treatment of urinary tract infections. J Antimicrob Chemother. 1994;33 (suppl A):31-41.
4. Kennedy RH. The new viewpoint toward spinal cord injuries. Ann Surg. 1946;124: 1057-1065
5. Kass EH. Chemotherapeutic and antibiotic drugs in the management of infections of the urinary tract. Am J Med. 1955;18(5):764-781.
6. Surkin J, Smith M, Penman A, Currier M, Harkey HL III, Chang YF Spinal Cord Injury Incidence in Mississippi: A Capture-Recapture Approach. J Trauma. 1998 Sep;45(3): 502-504.
7. Gribble MJ, McCallum NM, Schechter MT. Evaluation of diagnostic criteria for bacteriuria in acutely spinal cord injured patients undergoing intermittent catheterization. Diagn Microbiol Infect Dis 1988; 9(4):197-206.
8. Stark RP, Maki DG. Bacteriuria in the catheterized patient: what quantitative level of bacteriuria is relevant? N Engl J Med. 1984; 311(9):560-564.
9. National Institute on Disability and Rehabilitation. The prevention and management of urinary tract infections among people with spinal cord injuries: National Institute on Disability and Rehabilitation Research Consensus Statement. J Am Paraplejia Soc 1992: 15: 194-204.
10. Esclarín De Ruz A, García Leoni E, Herruzo Cabrera R. Epidemiology and Risk factor for urinary tractus infeccion in patients with spinal cord injure. J Urol. 2000; 164(4): 1285-1289.
11. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002 Jul 8; 113 Suppl 1A: 5S-13S.
12. Penders J, Huylenbroeck AA, Everaert K, Van Laere M, Verschraegen GL. Urinary infections in patients with spinal cord injury. Spinal Cord. 2003 Oct;41(10):549-552.
13. Kaufman JM, Fam B, Jacobs SC, Gabilondo F, Yalla. S, Kane JP, Rossier AB: Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol. 1977;118(6): 967-997.
14. Subramanian Vaidyanathan, Paul Mansour, Bakul M Soni, Gurpreet Singh and Pradipkumar Sett. The method of bladder drainage in spinal cord injury patients may influence the histological changes in the mucosa of neuropathic bladder -a hypothesis. BMC Urology 2002;2:5.
15. Contreras OR, Roura G, Fernandez D Diagnosis from urine culture in 4 hours using the DIRAMIC-03 system.Rev Latinoam Microbiol. 1992; 34(2):83-86.
16. Alarcón RC, Ruiz FT, Tamayo AZ, Carmona GR, Varela EA, Ochoa GT, Frómeta NR. Mycrob-1000: an alternative for the rapid determination of urine culture in the primary health level]. Rev Cubana Med Trop, Mayo-ago. 2004;56(2):135-138.
17. Shah PS, Cannon JP, Sullivan CL, Nemchausky B, Pachucki CT. Controlling Antimicrobial Use and Decreasing Microbiological Laboratory Tests for Urinary Tract Infections in Spinal-CordInjury Patients with Chronic Indwelling Catheters. Am J Health-Syst Pharm. 2005; 62(1):74-77.
18. WHO/CDS/CSR/EPH/2002. Prevenciṕn de las infecciones nosocomiales. Guia Práctica. [Sitio en Internet] Disponible en: http:/www.who. int/csr/resources/publications/drugresist/en/PISpanish3.pdf. Con acceso el 14 de julio de 2005.
19. Bennett CJ, Young MN, Darrington H. Differences in urinary tract infections in male and female spinal cord injury patients on intermittent catheterisation. Paraplegia. 199; 33(2):69-72.
20. Waites KB, Canupp KC, DeVivo MJ. Microbiology of the urethra and perineum and its relationship to bacteriuria in community-residing men with spinal cord injury. 2004; 27(5):448-52.
21. Delavierre D. Orchi-epididymitis. Ann Urol (Paris). 2003; 37(6):322-338.
22. Ozkan B, Demirkesen O, Durak H, Uygun N, Ismailoglu V, Cetinel B. Which factors predict upper urinary tract deterioration in overactive e neurogenic bladder dysfunction? Urology. 2005 Jul;66(1):99-104.
23. Ken Waites. Epidemiology of Antimicrobial Resistance in Spinal Cord Injury. Volume 16, Number 2: Summer, 1998. 619 19th St S, Birmingham, AL 35249-7330.
24. Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother. 2001;45(5):1402-1406.
25. Jacoby G, Archer G. New Mechanisms of Bacterial Resistance to Antimicrobial Agents. New Engl J Med. 1991;324: 601.
26. Muder RR, Brennen C, Drenning SD, Stout JE, Wagener MM. Multiple antibiotic-resistant gram-negative bacilli in a long-term-care facility: a case-control study of patient risk factors and prior antibiotic use. Infect Control Hosp Epidemiol. 1997;18(12):809-813.
27. Yoshida H., Bogaki M., Nakamura M., & Nakamura S. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 1990;34(6):1271-1972.
28. Schaeffer AJ. Review of norfloxacin in complicated and recurrent urinary tract infections. Eur Urol. 1990;17 Suppl. 1: 19-23.
29. Estrategia mundial OMS de contención de la resistencia a los antimicrobianos - Resumen. WHO/CDS/CSR/DRS/2001.2a
30. Erik R, Dubberke, MD, Victoria J, Fraser, MD. Cycling and Other Strategies to Slow and Reverse Antibiotic Resistance, Washington University School of Medicine, St Louis Infect Med. 2004;21(11):544-556.
31. Stelling J, Travers K, Jones R, Philip PJ, O'Brien T, and Levy SB. Integrating Escherichia coli Antimicrobial Susceptibility Data from Multiple Surveillance Programs. Emerging Infectious Diseases. Current Issue. 2005. 11(6): 873-882.
32. Goettsch W, van Pelt W, Nagelkerke N, Hendrix MG, Buiting AG, Petit PL. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother. 2000;46(2): 223-228.
33. Yamane K, Wachino J, Doi Y, Kurokawa H and Arakawa Y. Global Spread of Multiple Aminoglycoside Resistance Genes. Vol. 11, No. 6 June 2005 Emerging Infectious Diseases Vol. 11, No. 6, June 2005. [Sitio en internet]. con acceso 9 de marzo 2006].
34. Shlaes DM, Gerding DN, John JF, Craig WA, Bornstein DL, Duncan RA, et al.Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997;25:584-599.
35. Fridkin SK. Routine cycling of antimicrobial agents as an infection-control measure. Clin Infect Dis. 2003;36:1438-1444.
36. Lindsay E.Thomas M, Wanda K. Fisher C;Fourcroy C, Gupta K, et al. Managing Acute Uncomplicated Cystitis in the Era of Antibiotic Resistance. [Sitio en Internet] Medscape. Disponible en: http:// www.medscape.com/iewprogram/2634_pnt. con acceso 10 de mayo 2005.